Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

YHNAU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 16
  • 0 comments

YHNAU attributes changed: Attr: Fin_status N -> D;

Comment Full text

YHNAR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 22
  • 0 comments

YHNAR attributes changed: Attr: Fin_status N -> D;

Comment Full text

YHNA attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 14
  • 0 comments

YHNA attributes changed: Attr: Fin_status N -> D;

Comment Full text

VVOS attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 17
  • 0 comments

VVOS attributes changed: Attr: Fin_status N -> D;

Comment Full text

VIVOS THERAPEUTICS, INC. (VVOS)

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 13
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

VRME attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 19
  • 0 comments

VRME attributes changed: Attr: Fin_status N -> D;

Comment Full text

SEGG attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 19
  • 0 comments

SEGG attributes changed: Attr: Fin_status N -> E;

Comment Full text

MIGI attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 17
  • 0 comments

MIGI attributes changed: Attr: Fin_status N -> D;

Comment Full text

MAPS attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 8
  • 0 comments

MAPS attributes changed: Attr: Fin_status D -> N;

Comment Full text

LTRYW attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 8
  • 0 comments

LTRYW attributes changed: Attr: Fin_status N -> E;

Comment Full text
  • Previous
  • 213
  • 214
  • 215
  • 216
  • 217
  • Next

Search

News categories

  • Technical Exchange News(14191)
  • Event(6229)
  • SEC News(362464)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222898)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin